metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-28 BODY COMPOSITION MEASUREMENT AND NONALCOHOLIC FATTY LIVER DISEASE
Información de la revista
Vol. 24. Núm. S1.
Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
(septiembre 2021)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 24. Núm. S1.
Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
(septiembre 2021)
Open Access
P-28 BODY COMPOSITION MEASUREMENT AND NONALCOHOLIC FATTY LIVER DISEASE
Visitas
532
Maria Auxiliadora Nogueira Saad, Débora Vieira Soares, Priscila Pollo Flores, Rosa Leonora Salerno Soares, Vinicius César Jardim Pereira, Maria Clara Brito Pontes
Universidade Federal Fluminense, Brazil
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Suplemento especial
Este artículo forma parte de:
Vol. 24. Núm S1

Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)

Más datos
Introduction

Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease, with a worldwide prevalence of 30%. The association between NAFLD and obesity, diabetes mellitus and metabolic syndrome is well established. It is estimated that approximately 76% of individuals with obesity, mainly visceral obesity, have NAFLD. Previous studies have shown that anthropometric measures to assess body fat, such as body mass index, neck circumference and waist circumference are predictors of NAFLD.

Objective

To assess the prevalence of NAFLD in obese individuals and the role of anthropometric measurements that estimate visceral fat as predictors of NAFLD.

Methods

Adults, over 18 years old, assisted in Antônio Pedro University Hospital, with risk of NAFLD (pre-diabetes, diabetes mellitus, metabolic syndrome, and obesity). All participants signed an informed consent form. Patient's clinical information, anthropometric, metabolic profiles were assessed. Non-invasive assessment of NAFLD was performed by ultrasound.

Results

The study group consisted of 40 subjects with predominance of females (87.5%). The prevalence of obesity was 55%. Higher diabetes and dyslipidemia in males (60% and 60%, respectively) when compared to females (51.4%, and 45.4%, respectively). Hepatic steatosis was present in 48.5% of women and 60% of men. Neck and waist circumference were greater in males (median 42 cm and 106.9 cm).

Conclusion

High prevalence of patients with obesity, fatty liver and metabolic diseases. High anthropometric measurements of visceral obesity in both sexes, demonstrating to be an important risk factor for NAFLD.

El Texto completo está disponible en PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos